Source matters: From phosphorus load to bioavailability

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 2, 2011, Pages 239-240

  Fukagawa, Masafumi ^a   Komaba, Hirotaka ^a   Miyamoto, Ken Ichi ^b  

^a TOKAI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORUS;

ABSORPTION; BIOAVAILABILITY; CHRONIC KIDNEY DISEASE; DIETARY INTAKE; EDITORIAL; FOOD INTAKE; HUMAN; MINERAL METABOLISM; NONHUMAN; PHOSPHATE BLOOD LEVEL;

BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; CHRONIC DISEASE; DIET, VEGETARIAN; DIETARY PROTEINS; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HOMEOSTASIS; HUMANS; KIDNEY DISEASES; MEAT; PHOSPHORUS, DIETARY; PLANT PROTEINS; TIME FACTORS;

EID: 79951891685     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11051210     Document Type: Editorial

References (15)

1. Block GA, Klassen PS, Lazarus JM, Ofshun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004 (Pubitemid 39031360)
2. Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kurokawa K: Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: Possible direct role of phosphorus. Nephron 70: 242-248, 1995
3. Oliveira RB, Cancela AL, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moyses RM: Early control of PTH and FGF23 in normophosphatemic CKD patients: A new target in CKD-MBD therapy? Clin J Am Soc Nephrol 5: 286-291, 2010
4. Hasegawa H, Nagano N, Urakawa I, Yamazaki Y, Iijima K, Fujita T, Yamashita T, Fukumoto S, Shimada T: Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early stage of chronic kidney disease. Kidney Int 78: 975-980, 2010
5. Katai K, Tanaka H, Tatsumi S, Fukunaga Y, Genjida K, Morita K, Kuboyama N, Suzuki T, Akiba T, Miyamoto K, Takeda E: Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine. Nephrol Dial Transplant 14: 1195-1201, 1999 (Pubitemid 29209307)
6. Kazama JJ: Oral phosphate binders: History and prospects. Bone 45[Suppl 2]: S8-S12, 2009
7. Kalanter-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy C, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple J: Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5: 519-530, 2010
8. Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, Marquisha MA, Sehgal AR: Effect of food additives on hyperphosphatemia among patients with end-stage renal disease. JAMA 301: 629-635, 2009
9. Sherman RA, Mehta O: Dietary phosphorus restriction in dialysis patients: Potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 54: 18-23, 2009
10. Schlemmer U, Frolich W, Prieto RM, Grases F: Phytate in food and significance for humans: Food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res 53: S330-S375, 2009
11. Moe SM, Chen NX, Seifert MF, Sinders RM, Duan D, Chen X, Liang Y, Radcliff JS, White KE, Gattone VH 2nd: A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 75: 176-184, 2009
12. Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliff JS, Trevino LL, Donahue SE, Asplin JR: Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 6: 257-264, 2011
13. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalanter-Zadeh K: Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88: 1511-1518, 2008
14. Mathewson AM, Fouque D, Toft AJ: Dietary phosphate assessment in dialysis patients. J Ren Nutr 20: 351-358, 2010
15. Koiwa F, Kazama JJ, Tokumoto A, Onoda N, Kato H, Okada T, Nii-Kono T, Fukagawa M, Shigematsu T: Sevelamer hydrochloride and calcium carbonate reduce serum FGF23 levels in dialysis patients. Ther Apher Dial 9: 328-330, 2005